clinical trial · NCT07805707
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, HumanmRNA Seasonal Flu vaccineLicensed Influenza Vaccine
brief summary
This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu season. The study will measure prevention of laboratory-confirmed flu illness, side effects, and immune responses.
started
Sep 2, 2026
primary completion
Jun 9, 2028
completion
Jun 9, 2028
last updated
Sep 18, 2026
official title
A Phase 3 Randomized, Observer-Blind, Controlled Study to Evaluate the Clinical Efficacy of an mRNA Based Seasonal Influenza Vaccine in Older Adults ≥65 Years of Age
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol